These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 929513)

  • 1. Factor VIII inhibitor by-passing activity (FEIBA) in the management of patients with factor VIII inhibitors.
    Preston FE; Dinsdale RC; Sutcliffe DJ; Bardhan G; Wyld PJ; Hamlyn JF
    Thromb Res; 1977 Nov; 11(5):643-51. PubMed ID: 929513
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.
    Parry DH; Bloom AL
    J Clin Pathol; 1978 Nov; 31(11):1102-5. PubMed ID: 739057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
    Zwahlen H; Beck EA
    Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated F IX concentrate (FEIBA).
    Stenbjerg S; Jorgensen J
    Scand J Haematol; 1977 May; 18(5):421-6. PubMed ID: 877518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The weak inhibitors of factor VIII in patients with hemophilia A].
    Mayer G; Noel G; Kalogjera V; Waitz R
    Blut; 1969; 19(9):517-28. PubMed ID: 5369477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factor VIII inhibitors].
    Albores Núñez MI; Pérez Llanderal JA; Telenti Vigón A
    Rev Clin Esp; 1968 Apr; 109(2):129-36. PubMed ID: 5739637
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.
    Sultan Y; Brouet JC; Debre P
    N Engl J Med; 1974 Nov; 291(20):1087. PubMed ID: 4414451
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of factor VIII inhibitor in hemophiliacs].
    Mancini AF; Rosito P; Paolucci G
    Minerva Pediatr; 1976 Nov; 28(36):2181-5. PubMed ID: 995099
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated intravascular coagulation and infusion of factor-VIII-inhibitor bypassing activity.
    Stenbjerg S; Jorgensen J
    Lancet; 1977 Feb; 1(8007):360. PubMed ID: 64875
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary hemorrhagic telangiectasia and factor VIII inhibitor.
    Sudarshan A; Natelson EA; Gordon C
    South Med J; 1985 May; 78(5):623-4. PubMed ID: 3922057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total dental extraction in a patient with F VIII inhibitor.
    Stenbjerg S; Tauris P; Skottun T; Jørgensen J
    Thromb Res; 1980 Jun; 18(6):889-93. PubMed ID: 6774444
    [No Abstract]   [Full Text] [Related]  

  • 12. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
    Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
    Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postpartum hemophilia A with factor VIII inhibitor].
    Neidhardt B; Bartels O; Hahn B
    Dtsch Med Wochenschr; 1985 May; 110(20):799-802. PubMed ID: 3922727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
    N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
    István L; Bariska I; Marton E
    Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor.
    Chavin SI; Siegel DM; Rocco TA; Olson JP
    Am J Med; 1988 Aug; 85(2):245-9. PubMed ID: 3135752
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
    Tourbaf KD; Dunlap BE; Ambrus JL; Rodman DJ; Atwal AJ
    J Med; 1982; 13(5-6):399-410. PubMed ID: 6820380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors.
    Sharp HK; McIlveen LP; Schuman NJ
    Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VIII inhibitors in haemophilia.
    Lancet; 1983 Apr; 1(8327):742-3. PubMed ID: 6132087
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.